St. Luke's Hospital and Health Network, Pennsylvania

Closed portfolio with a later-stage archive tilt

According to ClinicalTrials.gov-derived indexes, St. Luke's Hospital and Health Network, Pennsylvania sits in the upper quartile of US sponsors by registered trial count (#1,604 of 15,742 sponsors by registered trial count).

8 total trials none currently recruiting 7 completed later-stage tilt upper quartile by trial count

St. Luke's Hospital and Health Network, Pennsylvania: 8 sponsored US clinical trials, none currently recruiting.

St. Luke's Hospital and Health Network, Pennsylvania sponsors 8 registered US clinical trials on ClinicalTrials.gov, none currently recruiting, and 7 completed. 1 of these trials are in Phase 3-4 (later-stage) and 0 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Melanoma, with 1 trials.

Upper-quartile sponsor footprint

St. Luke's Hospital and Health Network, Pennsylvania sits in the upper quartile of the sponsor corpus (#1,604 of 15,742 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.

Indexed trials (enrollment closed)

8 total, page 1 of 1

COMPLETED

Shoulder Symptom Irritability Scale: A Single-Blinded Observational Study

NCT02995941
TERMINATED NA

Use of NAC in Prevention of Hangover Symptoms; Independent Alcohol Consumption Protocol

NCT03104959
COMPLETED NA

Breath and Blood Ammonia Response to an Oral Protein Challenge

NCT02650245
COMPLETED NA

Accuracy of Self-estimation of Blood Alcohol Concentration Compared to Object Values

NCT02722564
COMPLETED NA

Use of NAC in Alleviation of Hangover Symptoms

NCT02541422
COMPLETED NA

Manipulation of Breath Alcohol Tests: Can Specific Techniques Alter Blood Alcohol Concentration Readings?

NCT02580318
COMPLETED

A Study to Compare Quality of Life and Compliance in Patients Receiving High-dose Interferon Versus Pegylated Interferon in Patients With Surgically Resected Melanoma

NCT01986712
COMPLETED Phase 4

A Trial of the Cost Effectiveness of IV Acetaminophen in Bariatric Surgery

NCT02233400

Phase Distribution

PhaseTrial count
Phase 4 1

Therapeutic Areas

Melanoma 1

How the St. Luke's Hospital and Health Network, Pennsylvania archive is shaped

8 indexed studies, none listed as recruiting (0% open); 7 completed (88%).

Phase mix: 1 late (III/IV) vs 0 early (I/II) (later-stage heavy).

Top condition: Melanoma (1 trial), 0 others listed.

How to read a closed sponsor archive

When recruiting_count is zero, the indexed set is completed or otherwise not open. Phase tilt still describes where archived studies sat on the investigational pathway. Re-check ClinicalTrials.gov before acting.

St. Luke's Hospital and Health Network, Pennsylvania: archived-pipeline peers nationwide

Peers matched on 8 indexed studies with no current recruiting: volume and archive shape, not condition overlap.

St. Luke's Hospital and Health Network, Pennsylvania sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 051015 0%10%20%30%40% Total trials Recruiting share St. Luke's Hospital and Health Network, PennsylvaniaAB ScienceAbbott Point of CareAbeona TherapeuticsAcademisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)10xBio22nd Century Group23andMe3-C Institute for Social Development
St. Luke's Hospital and Health Network, Pennsylvania sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

St. Luke's Hospital and Health Network, Pennsylvania sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 8 archived trials

Sponsors with similar archive density (± trial count)

Related

Read our methodology - how this data is sourced, computed, and verified.

What to do with this St. Luke's Hospital and Health Network, Pennsylvania page

8 registered trials is a research-attention snapshot, not an endorsement of St. Luke's Hospital and Health Network, Pennsylvania or any single study.

  • None of St. Luke's Hospital and Health Network, Pennsylvania's trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
  • Melanoma is the condition St. Luke's Hospital and Health Network, Pennsylvania studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Melanoma trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. St. Luke's Hospital and Health Network, Pennsylvania pipeline card: 8 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.